carbamates has been researched along with ly3000328 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chan, M; DeBrota, DJ; Deeg, MA; LaBell, ES; Payne, CD; Shen, T; Tan, LH | 1 |
Autenrieth, IB; Beifuss, B; Bender, A; Frick, JS; Gronbach, K; Harmening, R; Kalbacher, H; Lange, A; Maerz, JK; Maurer, A; McCoy, K; Menz, S; Michaelis, L; Schäfer, A; Steimle, A | 1 |
Ji, FH; Liu, H; Meng, XW; Peng, K; Song, SY; Xia, Z; Yan, B | 1 |
1 trial(s) available for carbamates and ly3000328
Article | Year |
---|---|
Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects.
Topics: Adult; Benzopyrans; Carbamates; Cathepsins; Humans; Male; Middle Aged; Protease Inhibitors | 2014 |
2 other study(ies) available for carbamates and ly3000328
Article | Year |
---|---|
Symbiotic gut commensal bacteria act as host cathepsin S activity regulators.
Topics: Animals; Bacteria; Bacteroides; Bacteroides Infections; Benzopyrans; Blotting, Western; Bone Marrow Cells; Carbamates; Cathepsins; Cells, Cultured; Colitis; Cytokines; Dendritic Cells; Gastrointestinal Microbiome; Gene Expression; Host-Pathogen Interactions; Immune Tolerance; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Symbiosis | 2016 |
Inhibition of cathepsin S attenuates myocardial ischemia/reperfusion injury by suppressing inflammation and apoptosis.
Topics: Animals; Animals, Newborn; Apoptosis; Benzopyrans; Carbamates; Cardiotonic Agents; Cathepsins; Disease Models, Animal; Gene Expression Regulation, Developmental; Humans; Inflammation; Mice; Myocardial Infarction; Protein Interaction Maps; Rats; Reperfusion Injury | 2021 |